About PeopleBio R&D
PeopleBio R&D is a company based in Seongnam-si (South Korea) founded in 2002.. The company has 60 employees as of December 31, 2024. PeopleBio R&D operates in a competitive market with competitors including Cytox, ADx NeuroSciences, Amprion, Durin Technologies and Adlyfe, among others.
- Headquarter Seongnam-si, South Korea
- Employees 60 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Peoplebio. Inc.
-
Annual Revenue
$2.53 M (USD)-16.2as on Dec 31, 2024
-
Net Profit
$-7.4 M (USD)31.94as on Dec 31, 2024
-
EBITDA
$-6.77 M (USD)27.03as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
60
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PeopleBio R&D
PeopleBio R&D is a publicly listed company on the KRX with ticker symbol 304840 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of PeopleBio R&D
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by PeopleBio R&D
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PeopleBio RD
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Peoplebio R&D Comparisons
Competitors of PeopleBio R&D
PeopleBio R&D operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytox, ADx NeuroSciences, Amprion, Durin Technologies and Adlyfe, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Prognostic tests for assessing dementia risk are developed.
|
|
| domain | founded_year | HQ Location |
Biomarker assays for neurodegenerative diseases are developed using custom antibodies.
|
|
| domain | founded_year | HQ Location |
Assay technology for misfolded proteins in neurodegenerative disorders is developed.
|
|
| domain | founded_year | HQ Location |
Developer of the diagnostic test for neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Develops biomarkers and diagnostic tests for amyloid-related diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Peoplebio R&D
Frequently Asked Questions about PeopleBio R&D
When was PeopleBio R&D founded?
PeopleBio R&D was founded in 2002.
Where is PeopleBio R&D located?
PeopleBio R&D is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
How many employees does PeopleBio R&D have?
As of Dec 31, 2024, the latest employee count at PeopleBio R&D is 60.
What is the annual revenue of PeopleBio R&D?
Annual revenue of PeopleBio R&D is $2.53M as on Dec 31, 2024.
What does PeopleBio R&D do?
PeopleBio RD was founded in 2002 in Seongnam-si, South Korea, as a molecular diagnostics firm. Focus is placed on immunoassays for detecting neurodegenerative conditions like Alzheimers and Parkinsons. The Multimer Detection System platform is utilized, involving sandwich ELISA tests with capturing and detection antibodies to identify protein multimers in CSF, plasma, exosomes, and body fluids. Tests are also created for therapeutic antibodies and spongiform encephalopathies.
Who are the top competitors of PeopleBio R&D?
PeopleBio R&D's top competitors include Amprion, ADx NeuroSciences and Cytox.
Is PeopleBio R&D publicly traded?
Yes, PeopleBio R&D is publicly traded on KRX under the ticker symbol 304840.
What is PeopleBio R&D's ticker symbol?
The ticker symbol of PeopleBio R&D is 304840 on KRX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.